Efficacy and Safety of Mepolizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis: A Single-Center Experience.

Autor: Abuzakouk M; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Isse S; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Wechsler M; Pulmonary and Critical Care Medicine, National Jewish Health, Denver, USA., Uzbeck M; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Namas RA; Rheumatology, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Ghorab O; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Idris A; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Wahla A; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Alhameli H; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Salvo F; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Zoumot Z; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE., Shafiq I; Respiratory and Allergy Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.

Publikováno v: Cureus [Cureus] 2024 Aug 31; Vol. 16 (8), pp. e68282. Date of Electronic Publication: 2024 Aug 31 (Print Publication: 2024).